John Crowley – Clip from Panel at FDA Foundation

BIO Vice Chair (and incoming CEO) John F. Crowley speaks at the Reagan-Udall Foundation for the FDA workshop about qualifying biomarkers to support rare disease regulatory pathways.
(Feb. 21, 2024)

source